Scion Neurostim, founded in 2007, is a medical device company dedicated to developing non-invasive neuromodulation devices aimed at treating central nervous system disorders, with a primary focus on migraines and Parkinson’s disease. Their mission is to enhance patient lives through innovative, user-friendly medical devices that can be utilized both in clinical settings and at home. Scion Neurostim’s flagship product is an affordable neurostimulator designed for ease of use and effective treatment.

Notable figures associated with Scion Neurostim include leading neurologists and medical researchers who contribute to the company's rigorous scientific studies and clinical trials. The company has garnered attention from investors interested in pioneering medical technologies. Key achievements include successful clinical trials demonstrating the efficacy of their devices in treating non-motor symptoms of Parkinson’s disease and migraines. Scion Neurostim has made a significant impact by providing accessible, non-invasive treatment options, improving the quality of life for patients worldwide.